We respect your privacy. Please consent to all cookies when you visit our website. Refer to our "Privacy Policy" for more information on how we handle personal data.

How can we help you today?

EN
Contact Us
  • 03-414.png
Medical Device Reg. No. 20262400346 (Guangdong)

Glial Fibrillary Acidic Protein (GFAP) Assay Kit

GFAP (glial fibrillary acidic protein) is a specific biomarker for astrocytes, and its elevated levels are closely linked to neuroinflammation and glial activation. In AD, the increase in GFAP levels reflects the activity level of neuroinflammation and is highly correlated with Aβ and tau pathological changes. By detecting blood GFAP levels, it can assist in the diagnosis of AD, evaluate disease severity, and monitor therapeutic efficacy, thereby providing comprehensive pathological information for clinical practice.

Inquire Now

  • Complete Product Line

    Offers a comprehensive product series to fully meet clinical multi-marker diagnostic needs based on the “A+T+N” standard

  • Leading Performance

    Optimized with self-developed core raw materials, sensitivity reaches sub-pg level.

  • High Automation, Rapid Testing

    Integrated with a high-performance fully automated instrument platform, single-tube loading; first report in 20 min.

  • Stable and Fast Results

    Testing throughput up to 200 T/H, intra-batch CV ≤ 8%, inter-batch CV ≤ 15%

  • Economic Advantage

    The overall solution offers significant cost advantages, effectively reducing the operational burden on medical institutions.

image.png